Authors:
CHOLLET DF
GOUMAZ L
RENARD A
MONTAY G
VERNILLET L
ARNERA V
MAZZO DJ
Citation: Df. Chollet et al., SIMULTANEOUS DETERMINATION OF THE LACTONE AND CARBOXYLATE FORMS OF THE CAMPTOTHECIN DERIVATIVE CPT-11 AND ITS METABOLITE SN-38 IN PLASMA BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 718(1), 1998, pp. 163-175
Authors:
SESSA C
CALDIERA S
DEJONG J
MONNERAT C
PERARD D
VERNILLET L
RIVA A
BESENVAL M
BAUER J
Citation: C. Sessa et al., PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 603-603
Authors:
CALDIERA S
BAUER J
DEJONG J
MONNERAT C
PERARD D
VERNILLET L
RIVA A
BESENVAL M
SESSA C
Citation: S. Caldiera et al., A CLINICAL AND PHARMACOKINETIC (PK) PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 359-359
Authors:
LATREILLE J
GELMON K
EISENHAUER E
TOLCHER A
FISHER B
VERNILLET L
DAIGNEAULT L
HOSTETLERYANOWITZ C
LEBECQ A
BESENVAL M
Citation: J. Latreille et al., PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 9, 1998, pp. 382-382
Authors:
FUMOLEAU P
TUBIANAHULIN M
SOULIE P
DELECROIX V
SISTAC F
MEFTI F
SOULAS F
APPIA F
LEBECQ A
VERGNIOL JC
VERNILLET L
RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387
Authors:
BAKER SD
RAVDIN P
AYLESWORTH C
SMETZER L
BRUNO R
VERNILLET L
PAZDUR R
DOYLE G
HAMMERSHAIMB L
HOOKER E
BURRIS HA
ECKHARDT SG
JOHNSON T
KRAYNAK M
HAMMOND L
RODRIGUEZ G
WEISS G
ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388
Authors:
ROUINI MR
LOTFOLAHI A
STEWART DJ
MOLEPO JM
SHIRAZI FH
VERGNIOL JC
TOMIAK E
DELORME F
VERNILLET L
GIGUERE M
GOEL R
Citation: Mr. Rouini et al., A RAPID REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODFOR THE DETERMINATION OF DOCETAXEL (TAXOTERE(R)) IN HUMAN PLASMA USING A COLUMN-SWITCHING TECHNIQUE, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1243-1247
Authors:
HAAZ MC
RIVORY L
RICHE C
VERNILLET L
ROBERT J
Citation: Mc. Haaz et al., METABOLISM OF IRINOTECAN (CPT-11) BY HUMAN HEPATIC MICROSOMES - PARTICIPATION OF CYTOCHROME-P-450 3A AND DRUG-INTERACTIONS, Cancer research, 58(3), 1998, pp. 468-472
Authors:
CARCAS AJ
FRIAS J
HERNANZ A
RUBIO ED
CORTESFUNES H
SASTRE J
PAZARES L
VERNILLET L
MARTIN C
HUARTE L
Citation: Aj. Carcas et al., PHARMACOKINETICS OF IRINOTECAN (CPT-11) AND 5-FLUOROURACIL (5-FU) IN A DOSE-FINDING STUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1121-1121
Authors:
PAPE D
VERNILLET L
BELLISSANT E
BENTUEFERRER D
ALLAIN H
Citation: D. Pape et al., NONINTERCHANGEABILITY OF SPECIFIC RADIOIMMUNOASSAY AND MONOCLONAL-ANTIBODY FLUORESCENT POLARIZATION IMMUNOASSAY IN CYCLOSPORINE MEASUREMENTS, Fundamental and clinical pharmacology, 10(5), 1996, pp. 484-489
Authors:
KOVARIK JM
VERNILLET L
MUELLER EA
FREIBURGHAUS R
NIEDERBERGER W
KUTZ K
Citation: Jm. Kovarik et al., CYCLOSPORINE DISPOSITION AND METABOLITE PROFILES IN RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION, Therapeutic drug monitoring, 16(5), 1994, pp. 519-525
Authors:
VERNILLET L
KOVARIK JM
FREIBURGHAUS R
SCHAUB P
MUELLER EA
NIEDERBERGER W
ZEHENDER H
Citation: L. Vernillet et al., BLOOD CYCLOSPORINE-A AND METABOLITE KINETIC PROFILES AFTER ADMINISTRATION OF SANDIMMUNE SOFT GELATIN CAPSULES AND NEORAL IN TRANSPLANT RECIPIENTS, Transplantation proceedings, 26(5), 1994, pp. 2964-2968
Authors:
GARDIER AM
MATHE D
GUEDENEY X
BARRE J
BENVENUTTI C
NAVARRO N
VERNILLET L
LOISANCE D
CACHERA JP
JACOTOT B
TILLEMENT JP
Citation: Am. Gardier et al., EFFECTS OF PLASMA-LIPID LEVELS ON BLOOD DISTRIBUTION AND PHARMACOKINETICS OF CYCLOSPORINE-A, Therapeutic drug monitoring, 15(4), 1993, pp. 274-280
Authors:
FOSTER RW
JUBBER AS
HASSAN NAGM
FRANKE B
VERNILLET L
DENOUEL J
CARPENTER JR
SMALL RC
Citation: Rw. Foster et al., TRIALS OF THE BRONCHODILATOR ACTIVITY OF THE XANTHINE ANALOG SDZ-MKS-492 IN HEALTHY-VOLUNTEERS DURING A METHACHOLINE CHALLENGE TEST, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 227-234